logo

For the Inventor, By the Inventor

Barcelona, Spain

Palobiofarma S.l.


USPTO Granted Patents = 12

% Expired Patents = 16.7



Forward Citations = 17

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Juan Camacho Gómez (6 out of 9 patents)

silverMedal Julio Cesar Castro-Palomino Laria (6 out of 16 patents)

bronzeMedal Juan Alberto Camacho Gomez (4 out of 4 patents)

4.  Julio Cesar Castro Palomino Laria (3 out of 18 patents)

5.  Weiyong Kong (2 out of 5 patents)

6.  Sanela Bilic (2 out of 3 patents)

7.  John Scott Cameron (2 out of 5 patents)

8.  Danny Roland Howard, Jr (2 out of 3 patents)

9.  Kai Cui (2 out of 5 patents)

10.  Abdelaziz El Maatougui (1 out of 1 patent)

11.  Adela Mendoza Lizaldez (1 out of 1 patent)

12.  Julio Castro-Palomino Lária (1 out of 2 patents)

13.  Lyhen Gonzalez Lio (1 out of 1 patent)

14.  Julio Castro Palomino Laria (1 out of 4 patents)

15.  Julio Castro- Palomino Laria (0 patent)


12 patents:

1. 12384754 - Cocrystals of (1R,3S)-3-(5-cyano-4-phenyl-1,3-thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid (2025-08-12),
2. 11654144 - Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1- yl)pyrimidin-4-amine and new salts (2023-05-23),
3. 11078191 - 1-(4-amino-5-bromo-6-(1H-pyrazol-1-yl)pyrimidin-2-yl)-1H-pyrazol-4-ol and use thereof in the treatment of cancer (2021-08-03),
4. 10933064 - Crystalline forms of 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine and new salts (2021-03-02),
5. 10744125 - Adenosine A3 receptor modulators (2020-08-18),
6. 10583127 - Amine salt of (1R, 3S)-3-(5-cyano-4-phenyl-1,3- thiazol-2-ylcarbamoyl)cyclopentane carboxylic acid (2020-03-10),
7. 10561653 - 5-bromo-2,6-di-(1H-pyrazol-1-yl)pyrimidin-4-amine for use in the treatment of cancer (2020-02-18),
8. 10253017 - [object Object] (2019-04-09),
9. 10238637 - Modulators of the adenosine A3 receptors (2019-03-26),
10. 9447095 - Pyrimidine derivatives as phosphodiesterase 10 inhibitors (PDE-10) (2016-09-20),
11. 8796284 - [object Object] (2014-08-05),
12. 8410282 - [object Object] (2013-04-02),
Company Overview
Palobiofarma S.L. is a biotechnology company based in Barcelona, Spain, specializing in the development of innovative therapeutic solutions. The organization focuses on the discovery and advancement of biologics and small molecules aimed at addressing unmet medical needs in various therapeutic areas, including oncology and autoimmune diseases. With a commitment to research and development, Palobiofarma leverages cutting-edge technologies to enhance drug efficacy and safety, contributing to the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

12 Patents

#57 in Barcelona

#176 in Spain

#48,129 in the World

Barcelona, ES
Barcelona, Spain

Palobiofarma S.l.

Forward Citations = 17

14 inventors:

goldMedal Juan Camacho Gómez (6 out of 9 patents)

silverMedal Julio Cesar Castro-Palomino Laria (6 out of 16 patents)

bronzeMedal Juan Alberto Camacho Gomez (4 out of 4 patents)

4.  Julio Cesar Castro Palomino Laria (3 out of 18 patents)

5.  Weiyong Kong (2 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Palobiofarma S.l.. Retrieved from https://idiyas.com/company/palobiofarma-s-l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…